Appointments and SchedulesNCT03055702
Using Mobile Phone Short Message Service (SMS) Reminders to Enhance Appointment Attendance in DM Patients
A study testing Mobile phone text message reminder in people with Appointments and Schedules and Diabetes Mellitus, Type 2, run by The University of Hong Kong at 1 site in Hong Kong.
Trial summary
A randomized controlled trial of patients with type 2 diabetes mellitus with multiple appointments into short message service group and control group. The attendance rate of these two groups of patients will be compared. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Appointments and Schedules, Diabetes Mellitus, Type 2
- What is being tested?
- Mobile phone text message reminder
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 270 participants
- Where
- 1 siteHong Kong
- Study dates
- 1 Nov 2016to 30 Mar 2018
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- With diagnosis of type 2 diabetes
- Have more than 1 clinic services appointment under RAMP-DM programme:
- (e.g. blood taking, diabetic nurse individual counselling, group education, diabetic complication screening, retinal photo assessment, dietician counselling, etc)
Who cannot join
- Cannot read or receive appointment schedule on mobile phone
- Do not speak Cantonese/English or read Chinese/English
- Mentally incapacitated
- Pregnant Women
Trial locations and contacts
1 site in 1 country.
Hong Kong1 site, 1 recruiting
- Recruiting
Ha Kwai Chung General Outpatient Clinic
Kwai Chung, Hong Kong, 000
Man Chi Dao, +85236515411, thomasmcdao@gmail.com
Man Chi Dao, M.B.B.S.
About this study
Official title: Using Mobile Phone Short Message Service (SMS) Reminders to Enhance Type 2 Diabetes Mellitus Appointment Attendance in a Primary Care Clinic
A randomized controlled trial of patients with type 2 diabetes mellitus with multiple appointments into short message service group and control group. The attendance rate of these two groups of patients will be compared.
Read the detailed description
The main objective of this study is to evaluate the appointment attendance rate using SMS reminder of nurses and allied health appointments for diabetic patients, when compared to conventional telephone reminder and no reminder. We also aim at determine the factors associated with appointment attendance. Finally, we will also survey patients' acceptance and satisfaction to the SMS service.
This is a single blind randomization study. It will be carried out in Ha Kwai Chung General Outpatient Clinic.
The primary outcome of this study is to evaluate the attendance rate of each individual doctor, nurses and allied health clinic appointments for diabetic patients, as well as their overall attendance rates:
- Diabetes Complication Screening Clinic (OPAS DMCS/RDNA)
- Diabetes Nurse Intervention Clinic (OPAS DMIC/RDNI)
- DM nurse group (OPAS RDNG)
- Dietitian Counselling (OPAS DC/DG)
- Physiotherapy (OPAS PTC/PTG)
- Diabetes Doctor Session (OPAS RDR)
- Retino photo Assessment (OPAS RDO)
- Blood taking appointment (OPAS LABT)
The secondary outcomes are:
- Acceptance Rate of SMS Reminder Vs Telephone Reminder Vs no reminder
- Factors associated with acceptance of SMS
- Personal Parameters: Age, sex, educational level, occupation, mobile phone models, Habit of using mobile phone service
- Disease Parameters: Number and types of comorbidity, disease control (by biochemical markers)
- Quality of Life (by SF-6D)
- Reported adverse effects of the reminder system
- Chang in biochemical markers (BMI, HbA1c, LDL-c level) 6-9 months later
Subjects who agreed to participate in this study will first receive a survey on the acceptance of SMS service. For those agree to receive SMS reminder, they will be randomized to:
- an SMS remind them to come for scheduled clinic appointment 24-72 hours before, or
- usual care with no reminder / telephone reminder.
- Being tested
- Mobile phone text message reminder
- Keywords
- Short Message Service, appointment reminder, Attendance rate
- Medical subject headings
- Diabetes Mellitus, Type 2
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Mobile phone text message reminderOther
an SMS remind subjects to come for scheduled clinic appointment 24-72 hours before
| Study group | Role | What they receive |
|---|---|---|
| SMS group | Experimental | receive a mobile phone text reminder for scheduled clinic appointment 24-72 hours before, Receives: Other: Mobile phone text message reminder |
| Usual care group | No intervention | Usual care, either telephone reminder or no reminder |
What is being measured
The primary outcome is the main question the study is designed to answer.
Attendance Rate of the scheduled clinic appointment
Attendance Rate
Measured: between booking time and appointment time, usually within 1 weeks to 16 weeks
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted16 Feb 2017
- Study start1 Nov 2016
- Primary completion30 Jun 2017 (estimated)
- Study completion30 Mar 2018 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Appointments and SchedulesStudies of the same condition, open and under way.
- More trials run by The University of Hong KongThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 270 participants (estimated)
Sponsor and investigators
- Lead sponsor
- The University of Hong Kong
- Sponsor type
- University, hospital or other
- Collaborators
- Hospital Authority, Hong Kong
- Responsible party
- Sponsor
- Investigators
- Man Chi Dao, M.B.B.S., Principal investigator, Resident
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03055702
- Sponsor's protocol ID
- KW/EX-16-104(100-10)
- Status last verified
- Feb 2017
- First submitted
- 14 Feb 2017
- Last updated
- 16 Feb 2017
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 16 Feb 2017. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Using Mobile Phone Short Message Service (SMS) Reminders to Enhance Type 2 Diabetes Mellitus Appointment Attendance in a Primary Care Clinic
- ClinicalTrials.gov ID
- NCT03055702
- Acronym / sponsor ID
- KW/EX-16-104(100-10)
- Keywords
- Short Message Service, appointment reminder, Attendance rate
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 270 participants (estimated)
- Lead sponsor
- The University of Hong KongUniversity, hospital or other
- Collaborators
- Hospital Authority, Hong Kong
- Study start
- 1 Nov 2016 (actual)
- Primary completion
- 30 Jun 2017 (estimated)
- Study completion
- 30 Mar 2018 (estimated)
- First posted
- 16 Feb 2017 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
A randomized controlled trial of patients with type 2 diabetes mellitus with multiple appointments into short message service group and control group. The attendance rate of these two groups of patients will be compared.
Detailed description
The main objective of this study is to evaluate the appointment attendance rate using SMS reminder of nurses and allied health appointments for diabetic patients, when compared to conventional telephone reminder and no reminder. We also aim at determine the factors associated with appointment attendance. Finally, we will also survey patients' acceptance and satisfaction to the SMS service.
This is a single blind randomization study. It will be carried out in Ha Kwai Chung General Outpatient Clinic.
The primary outcome of this study is to evaluate the attendance rate of each individual doctor, nurses and allied health clinic appointments for diabetic patients, as well as their overall attendance rates:
- Diabetes Complication Screening Clinic (OPAS DMCS/RDNA)
- Diabetes Nurse Intervention Clinic (OPAS DMIC/RDNI)
- DM nurse group (OPAS RDNG)
- Dietitian Counselling (OPAS DC/DG)
- Physiotherapy (OPAS PTC/PTG)
- Diabetes Doctor Session (OPAS RDR)
- Retino photo Assessment (OPAS RDO)
- Blood taking appointment (OPAS LABT)
The secondary outcomes are:
- Acceptance Rate of SMS Reminder Vs Telephone Reminder Vs no reminder
- Factors associated with acceptance of SMS
- Personal Parameters: Age, sex, educational level, occupation, mobile phone models, Habit of using mobile phone service
- Disease Parameters: Number and types of comorbidity, disease control (by biochemical markers)
- Quality of Life (by SF-6D)
- Reported adverse effects of the reminder system
- Chang in biochemical markers (BMI, HbA1c, LDL-c level) 6-9 months later
Subjects who agreed to participate in this study will first receive a survey on the acceptance of SMS service. For those agree to receive SMS reminder, they will be randomized to:
- an SMS remind them to come for scheduled clinic appointment 24-72 hours before, or
- usual care with no reminder / telephone reminder.
Study design
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| SMS group | Experimental | Other: Mobile phone text message reminderreceive a mobile phone text reminder for scheduled clinic appointment 24-72 hours before, |
| Usual care group | No intervention | –Usual care, either telephone reminder or no reminder |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- With diagnosis of type 2 diabetes
- Have more than 1 clinic services appointment under RAMP-DM programme:
- (e.g. blood taking, diabetic nurse individual counselling, group education, diabetic complication screening, retinal photo assessment, dietician counselling, etc)
Key exclusion criteria (4 listed)
- Cannot read or receive appointment schedule on mobile phone
- Do not speak Cantonese/English or read Chinese/English
- Mentally incapacitated
- Pregnant Women
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Mobile phone text message reminderan SMS remind subjects to come for scheduled clinic appointment 24-72 hours before | Other | SMS group |
Primary outcome
Attendance Rate of the scheduled clinic appointment
Time frame: between booking time and appointment time, usually within 1 weeks to 16 weeks
Attendance Rate
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 16 Feb 2017.
- Individual participant dataSharing planned: Undecided
Related trials for Appointments and Schedules
Recruiting
Enhancing Operational Efficiency in Eye Care Services
Quality Improvement, Appointments and Schedules
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Man Chi Dao, M.B.B.S. principal investigator
Resident
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Mobile phone text message reminder in people with Appointments and Schedules and Diabetes Mellitus, Type 2, run by The University of Hong Kong at 1 site in Hong Kong.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 16 Feb 2017. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Hong Kong. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Man Chi Dao, M.B.B.S. (+85236515411, thomasmcdao@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Attendance Rate of the scheduled clinic appointment (time frame: between booking time and appointment time, usually within 1 weeks to 16 weeks). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Feb 2017.